An Engineer Who Used AI and mRNA to Save His Dog from Terminal Cancer

This episode looks at a remarkable case where an Australian engineer developed a personalized mRNA vaccine for his dog, who had been diagnosed with terminal cancer.At first, it might sound like something anyone could do with AI, but the reality is more complex.The process involved significant resources, collaboration with university researchers, and formal ethical approvals.What makes the story interesting is not just the outcome, but how existing tools—like AI assistants and protein prediction systems such as AlphaFold—were used to navigate a highly specialized field.It also highlights a key feature of mRNA technology: its potential for personalization.Instead of mass-produced treatments, it allows for designs tailored to individual cases.This is not a broadly repeatable example yet, but it suggests how AI can help bridge gaps between fields and make advanced approaches more accessible over time.Overall, it offers a glimpse into how AI, biology, and human initiative are starting to intersect in new ways.